Suppr超能文献

与培养分离株的肉汤微量稀释法和纸片扩散法抗生素敏感性试验相比,汇总抗生素敏感性试验在验证时符合CLSI标准。

Pooled Antibiotic Susceptibility Testing Performs Within CLSI Standards for Validation When Measured Against Broth Microdilution and Disk Diffusion Antibiotic Susceptibility Testing of Cultured Isolates.

作者信息

Haley Emery, Cockerill Frank R, Pesano Rick L, Festa Richard A, Luke Natalie, Mathur Mohit, Chen Xiaofei, Havrilla Jim, Baunoch David

机构信息

Department of Clinical Research, Pathnostics, Irvine, CA 92618, USA.

Independent Researcher, Trusted Health Advisors, Orange, CA 92675, USA.

出版信息

Antibiotics (Basel). 2024 Dec 14;13(12):1214. doi: 10.3390/antibiotics13121214.

Abstract

: While new methods for measuring antimicrobial susceptibility have been associated with improved patient outcomes, they should also be validated using standard protocols for error rates and other test metrics. The objective of this study was to validate a novel susceptibility assay for complicated and recurrent urinary tract infections (UTIs): pooled antibiotic susceptibility testing (P-AST). This assay was compared to broth microdilution (BMD) and disk diffusion (DD), following Clinical and Laboratory Standards Institute (CLSI) guidelines for assessment of error rates and agreement. : This study analyzed consecutive fresh clinical urine specimens submitted for UTI diagnostic testing. Upon receipt, the urine samples were subjected in parallel to standard urine culture and multiplex polymerase chain reaction (M-PCR) for microbial identification and quantification. Specimens with the same monomicrobial non-fastidious bacteria detected by both M-PCR and standard urine culture (SUC) underwent standard antibiotic susceptibility testing (AST) and P-AST antibiotic susceptibility testing. Analysis was also undertaken to assess the presence of heteroresistance for specimens with P-AST-resistant and BMD/DD consensus-susceptible results. : The performance measures without correction for heteroresistance showed essential agreement (EA%) of ≥90%, very major errors (VMEs) of <1.5%, and major errors (MEs) of <3.0% for P-AST, all meeting the threshold guidelines established by CLSI for AST. The categorical agreement (CA%) also met acceptable criteria (>88%), as the majority of the errors were minor (mEs) with essential agreement. The very major and major error rates for P-AST decreased to <1.0% when heteroresistance was accounted for. The P-AST assay methodology is validated within acceptable parameters when compared to broth microdilution and disk diffusion using CLSI criteria.

摘要

虽然测量抗菌药物敏感性的新方法已与改善患者预后相关联,但它们也应使用关于错误率和其他测试指标的标准方案进行验证。本研究的目的是验证一种用于复杂和复发性尿路感染(UTI)的新型敏感性检测方法:混合抗生素敏感性试验(P-AST)。按照临床和实验室标准协会(CLSI)评估错误率和一致性的指南,将该检测方法与肉汤微量稀释法(BMD)和纸片扩散法(DD)进行比较。

本研究分析了提交用于UTI诊断检测的连续新鲜临床尿液标本。收到标本后,将尿液样本并行进行标准尿培养和多重聚合酶链反应(M-PCR)以进行微生物鉴定和定量。通过M-PCR和标准尿培养(SUC)检测到相同单一非苛养菌的标本进行标准抗生素敏感性试验(AST)和P-AST抗生素敏感性试验。还进行了分析,以评估P-AST耐药而BMD/DD一致敏感的标本中异质性耐药的存在情况。

未校正异质性耐药的性能指标显示,P-AST的基本一致性(EA%)≥90%,极重大错误(VME)<1.5%,重大错误(ME)<3.0%,均符合CLSI为AST制定的阈值指南。分类一致性(CA%)也符合可接受标准(>88%),因为大多数错误为基本一致的微小错误(mE)。考虑异质性耐药时,P-AST的极重大和重大错误率降至<1.0%。与使用CLSI标准的肉汤微量稀释法和纸片扩散法相比,P-AST检测方法在可接受参数范围内得到了验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f46/11672409/ab7634de59d5/antibiotics-13-01214-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验